Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Palomar Holdings PLMR 24. avr 2025 153.15 +0.76   
 Palvella Therapeutics PVLA 24. avr 2025 25.47 -4.10   
 Pampa Energia ADR PAM 24. avr 2025 76.05 -1.64   
 PAMT Corp PAMT 24. avr 2025 14.09 +1.22   
 Pan American Silver PAAS 24. avr 2025 26.01 +1.29   
 Pangaea PANL 24. avr 2025 4.28 +0.71   
 Papa Johns International PZZA 24. avr 2025 33.19 +1.37   
 Par Pacific PARR 24. avr 2025 14.54 +3.93   
 PAR Technology PAR 24. avr 2025 59.46 +3.57   
 Paragon 28 FNA 24. avr 2025 13.09 0.00   
 Paramount Global A PARAA 24. avr 2025 22.49 -1.27   
 Paramount Global B PARA 24. avr 2025 11.43 +2.05   
 Paramount Gold Nevada PZG 24. avr 2025 0.40 +6.74   
 Paramount Group PGRE 24. avr 2025 4.31 -0.92   
 Paranovus Entertainment Technology A PAVS 24. avr 2025 1.31 -0.82   
 ParaZero Technologies PRZO 24. avr 2025 0.61 +2.83   
 Park Aerospace PKE 24. avr 2025 13.23 -0.15   
 Park Hotels & Resorts PK 24. avr 2025 9.99 +1.01   
 Park National PRK 24. avr 2025 148.78 +0.59   
 Park-Ohio PKOH 24. avr 2025 19.59 +2.35   
 Parke Bancorp PKBK 24. avr 2025 19.07 +0.87   
 Parker-Hannifin PH 24. avr 2025 596.81 +2.75   
 Parsons PSN 24. avr 2025 67.33 +3.47   
 Pasithea Therapeutics KTTA 24. avr 2025 1.72 +5.52   
 Passage Bio PASG 24. avr 2025 0.33 -3.27   
 Pathfinder Bancorp PBHC 24. avr 2025 15.23 -1.55   
 Pathward Financial CASH 24. avr 2025 79.32 +0.47   
 Patria Investments A PAX 24. avr 2025 10.39 +2.47   
 Patria Latin American Opportunity Acquisition A PLAO 24. avr 2025 11.85 0.00   
 Patrick Industries PATK 24. avr 2025 79.96 +2.57   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.